Here's Why Pediatrix Medical Group (MD) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Pediatrix Medical Group (MD) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here Is Why Bargain Hunters Would Love Fast-paced Mover Pediatrix Medical Group (MD)
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Pediatrix Medical Group (MD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wall Street Analysts Think Pediatrix Medical Group (MD) Could Surge 27.97%: Read This Before Placing a Bet
The consensus price target hints at a 28% upside potential for Pediatrix Medical Group (MD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Fast-paced Momentum Stock Pediatrix Medical Group (MD) Is Still Trading at a Bargain
Pediatrix Medical Group (MD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Pediatrix Medical Stock Rallies 37.7% in 6 Months: More Room to Run?
MD is expected to benefit from rising patient volumes, a favorable payer mix and streamlining initiatives.
Wall Street Analysts Believe Pediatrix Medical Group (MD) Could Rally 25.5%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 25.5% in Pediatrix Medical Group (MD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
MD Gains 11% Since Q4 Earnings Release, Unveils '25 View
Pediatrix Medical's fourth-quarter results reflect a declining overall expense level. It estimates 2025 net income to lie within $98.3-$112.9 million.
Pediatrix Medical Group, Inc. (MD) Q4 2024 Earnings Call Transcript
Pediatrix Medical Group, Inc. (NYSE:MD ) Q4 2024 Earnings Conference Call February 20, 2025 9:00 AM ET Company Participants Charles Lynch - Senior Vice President, Finance & Strategy Mark Ordan - Chief Executive Officer Kasandra Rossi - Executive Vice President, Chief Financial Officer & Treasurer Conference Call Participants A.J. Rice - UBS Jack Levin - Jefferies Whit Mayo - Leerink Partners Benjamin Shaver - Deutsche Bank Operator Thank you for standing by.
Pediatrix Medical Group (MD) Surpasses Q4 Earnings and Revenue Estimates
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.32 per share a year ago.
Pediatrix Medical Gears Up for Q4 Results: What to Expect?
MD's fourth-quarter results are likely to reflect declining revenues and expenses.
